Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...
Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...
Detailed price information for Theralase Technologies Inc (TLTFF) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback